Cultivating Health

Currently, no THC or Cannabis flower products are sold or produced through this site.

Shop Now

About Us

Research & Development

Green Essence Florida’s mission is to lead research and development and advance innovation in medical cannabis from seed to sale in order to significantly improve the well being and quality of life of its customers. GEF plans to run a high efficiency and green friendly operation. It has partnered with medical experts leading cannabis research in cancer, Sickle Cell Disease, and other ailments that disproportionately affect Black populations. The Company expects to be a driver of clinical breakthroughs and plans to bring increased efficacy in the treatment of debilitating medical conditions by using CBD and medical cannabis. GEF has a strong customer-centric product focus. The team intends to develop customer-centric product lines with formulations for patient care, health and wellness, as well as a range of infused culinary products.

Our Promise to You

In order to provide our patients with the highest level of care, our goal is to create a treatment plan that will best suit your needs. We are developing technology to better serve the patient by connecting targeted research based on a patient's profile and biometrical factors. Our promise is to fill the gaps in your treatment plan through the support of the Essence Spa and Cannabis Treatment Center, Green Essence Florida dispensary network and GE subscription based plans. We recognize that often patients find themselves in a trail and error scenario because of a lack of pertinent information and consideration of biometrics. Our promise is to help patients find the best treatment plan for them, not what's trending, not the highest percentages, but what truly works best for their body.

Quality, Compassionate Care

Green Essence Florida is a company positioned to change the lives of Floridians with a patient-focused vertically integrated MMTC business model that is founded on the strength of research and development, and clinical results. Green Essence Florida relies on the strength of our medical director, research director and cultivation team to grow medical products with optimal efficiency. At Green Essence Florida, we have a vision with a simple goal — to give our patients the best quality of life by treating debilitating medical conditions with the scientifically-demonstrated benefits of cannabis. We are led and guided by the highest principles of integrity in medically supervised patient care treatments. Our team is led by neurosurgeon Dr. Anthony Hall, our highly qualified and experienced Medical Director.

MEET TEAM GREEN ESSENCE FLORIDA

Jasmine Johnson, CEO Green Essence Florida

Jasmine Johnson, Chief Executive Officer

Ms. Jasmine Johnson has over 10 years of executive leadership experience in asset management, hospitality, and tourism management. Ms. Johnson co-founded several successful businesses in the hospitality industry and the technology space before starting the venture of Green Essence Florida.

Ms. Johnson is the Vice President of Johnson Property Management Services and serves with the Greater Miami Chamber of Commerce, NAACP, Global Blockchain Association, and the Transportation Planning Organization. For the past 4 years, Jasmine has been responsible for the building the critical team members and development of the market entry strategy.

Ms.Johnson will serve as CEO for Green Essence with the vision and energy to change the Florida cannabis market.

Shelly Tallabas, COO Green Essence Florida

SHELLY TALLABAS, President

Ms. Shelly Tallabas is a results-driven executive with over 20 years of experience in product development, P&L management, and commercialization. Ms. Tallabas has more than 10 years of experience in the cannabis and hemp industry. Ms. Tallabas has a decade of direct experience in cannabis and hemp and is committed to advancing the overall stability and maturity of the industry by institutionalizing best-in- class CPG disciplines, analytic rigor, and proven engineered standards to the ever- evolving landscape.

Previously Ms. Tallabas was Head of Innovation & Manufacturing for Canndescent, leading them from flower to extraction while bringing their first oil and edible products to market and expanding the brand into multiple states. Prior, Shelly also served as Senior Vice President of Innovation at MedMen Enterprises where she led the development and launch of the brand (over 60 SKUs) and the first company-owned brand in cannabis. Prior to her involvement in the cannabis industry,

Ms. Tallabas spent two decades in food and beverage industry for Cadbury, Dr. Pepper Snapple Group and Yum Brands (Taco Bell, KFC) leading advertising development, product innovation, and retail trade marketing to drive incremental sales valued at more than $150B.

Our Team

Medical Director

Master Geneticist

Medical Director

Dr. Anthony Hall, MDCM, FACS is a Board-Certified neurosurgeon. He started practicing medicine in 1995 in Florida with a focus on neurological trauma and a wide scope of neurosurgery. In the last 10+ years, Dr. Hall has focused on elective surgery. He founded the Academy of Neurosurgical Physicians in Florida in 2002. Prior to then, he established the Miami Neurosurgical Associates and South Florida Neurosurgical Institute. Dr. Hall is also a member of a general medical practice in Kingston, Jamaica. He has been treating patients with medical cannabis for the past 5 years in Florida and for over 5.5 years in Jamaica.

Dr. Hall has treated hundreds of adults and pediatric patients in Florida and Jamaica with medical cannabis for a wide spectrum of ailments including different types of cancer (brain, spinal, hepatic, bone, ovarian, hematologic, prostate, stomach, and breast cancer), epilepsy and muscle spasms. Patient responses to the medical marijuana treatment have recorded dramatic results, equivocal results, and very minimal results. The latter has been observed in terminal patients with stage 4 cancer with many metastases who had come late to treatment. He will lead the Research & Development and Clinical vision for Green Essence Florida.

Show Less

Research Director

Master Geneticist

Medical Director

Dr. Lanetta Bronte-Hall is a leading national and international researcher and population health scientist in the field of sickle cell disease, rare blood disorders, community based participatory research, and chronic disease management. Dr. Bronte-Hall is the President, Chief Executive Officer, and Chief Health Officer for the Foundation of Sickle Cell Disease Research. She is also the Chief Medical Officer at the Sickle Cell Disease Association of America Inc. Dr. Bronte-Hall was been involved with Sickle Cell Disease (SCD) and SCD research since 2001. Lanetta did research in SCD at the Duke University Comprehensive Sickle Cell Center, where she had her first introduction to sickle cell patients. Lanetta’s current focus is policy, administration, advocacy and research for SCD. Dr. Bronte-Hall has extensive experience and knowledge of clinical trials and observational studies. Lanetta has been working in the Florida community with the Sickle Cell Program since 2015. There, her team focuses on providing medical care, primary care services for sickle cell patients and clinical research. The clinical research involves focus on the treatment of pain in sickle cell patients and how cannabis can be used to manage pain and reduce the use of opioids. Dr. Bronte-Hall’s primary role at Green Essence Florida will include involvement with protocol development, management of clinical trials, assessing the need for an institutional review board, and monitoring participating trial patients.

Show Less

Master Geneticist

Priest Douglas Smith has over 30 of experience as a holistic practitioner and naturopathic herbalist. Mr. Smith is a member of the Cannabis technical committee, a select group of knowledgably advisors working with the Bureau of Standards of Jamaica and the cannabis Licensing authority to create the standards which construct the cannabis industry’s regulations. He as the recipient of the 2019 Bureau of Standards of Jamaica Award for his invaluable contributions to the newly drafted standards that govern the Medical Ganja Industry of Jamaica. Priest collaborated with overseas specialists who have been using artificial intelligence to scientifically determine what strain of the cannabis plant is best suited to be combined with other strains to create the hybrids desired for treatment of specific ailments. AI helps determine the genetics of the needed strains and also identifies the properties of each plant that combines best for treating different diseases. Science based strains. Douglas seeks to grow sterile crops of cannabis, free of contaminants and toxins with the highest quality and level of medicine using standard operating/growing procedures. His experience with cannabis has led him to identify certain genotypes and phenotypes of the cannabis plants used for decades as medicine. He also seeks to cross several strains and breed new strains with heightened ratios of certain cannabinoids that will be used to create medical compounds and products to be used in clinical trials.

Show Less

Cultivating Health